Masamichi Kurosaki
7PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 11, 2026
Correction: Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression.Irfan Kesumayadi, Atsushi Kambe, Haruto Kanda
|Feb 05, 2026
Efficacy and safety profiles of single versus multiple pipeline embolization devices for intracranial aneurysms: a systematic review and meta-analysis.Irfan Kesumayadi, Makoto Sakamoto, Hidefumi Amisaki
|Feb 01, 2026
Drug-induced hypertension is associated with improved survival in glioblastoma patients treated with bevacizumab: evidence from a time-to-event meta-analysis and meta-regression.Irfan Kesumayadi, Atsushi Kambe, Hidefumi Amisaki
|Jan 10, 2026
Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression.Irfan Kesumayadi, Atsushi Kambe, Haruto Kanda
|Nov 12, 2025
Diagnostic criteria for acquired hypothalamic obesity - international expert guidance document.Hermann L Müller, Tomohiro Tanaka, Tomonobu Hasegawa
|Sep 09, 2025
Prognostic value of hypertension timing for survival in glioblastoma patients receiving bevacizumab: a retrospective single centre analysis.Irfan Kesumayadi, Atsushi Kambe, Hidefumi Amisaki
Pageof 2
Frequent Collaborators
6 joint publications
Irfan Kesumayadi
6 joint publications
Atsushi Kambe
6 joint publications
Makoto Sakamoto
1 joint publications
Hermann L Müller
1 joint publications
Tomohiro Tanaka
1 joint publications
Tomonobu Hasegawa
1 joint publications
Tsuyoshi Isojima
1 joint publications
Jun Mori
1 joint publications
A Ram Hong
1 joint publications
Ja Hye Kim
